Cargando…

Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions

Lead (Pb), cadmium (Cd) and aluminum (Al) were determined in 437 individual samples of infant formulae, oral electrolytes and 5% glucose solutions available in Canada. In the electrolytes, Cd and Pb concentrations were all below 0.01 and 0.041 ng g(−1), respectively. In the 5% glucose solutions, Pb...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabeka, Robert, Fouquet, Andre, Belisle, Stephane, Turcotte, Stephane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118527/
https://www.ncbi.nlm.nih.gov/pubmed/21623498
http://dx.doi.org/10.1080/19393210.2011.571795
_version_ 1782206484262682624
author Dabeka, Robert
Fouquet, Andre
Belisle, Stephane
Turcotte, Stephane
author_facet Dabeka, Robert
Fouquet, Andre
Belisle, Stephane
Turcotte, Stephane
author_sort Dabeka, Robert
collection PubMed
description Lead (Pb), cadmium (Cd) and aluminum (Al) were determined in 437 individual samples of infant formulae, oral electrolytes and 5% glucose solutions available in Canada. In the electrolytes, Cd and Pb concentrations were all below 0.01 and 0.041 ng g(−1), respectively. In the 5% glucose solutions, Pb and Cd levels averaged 0.01 and 0.09 ng g(−1), respectively. Reported on an as-consumed basis, Pb levels in milk- and soya-based formulae averaged 0.90 and 1.45 ng g(−1), respectively, while Cd levels averaged 0.23 and 1.18 ng g(−1), respectively Average Al levels on an as-consumed basis were 440 ng g(−1) (range 10–3400 ng g(−1)) in milk-based formulae and 730 ng g(−1) (range 230–1100 ng g(−1)) in soy-based formulae. Al concentrations increased in the following order: plain formula < low-iron formula < iron-supplemented formula < casein hydrolysate formula ≈ premature formula ≤ soy formula. For example, in the powdered formulae, average Al concentrations were 18 ng g(−1) for plain milk-based, 37 ng g(−1) for low-iron, 128 ng g(−1) for iron supplemented, 462 ng g(−1) for lactose-free, 518 ng g(−1) for hypoallergenic and 619 ng g(−1) for soy-based formula. Al concentrations, as-consumed, increased with decreasing levels of concentration: powder < concentrated liquid < ready-to-use. Formulae stored in glass bottles contained between 100 and 300 ng g(−1) more Al than the same formulae stored in cans. The source of the increased Al did not appear to be the glass itself, because most electrolytes and glucose solutions, also stored in glass, contained less than 8 ng g(−1) Al. Corresponding differences in Pb and Cd levels were not observed. Al concentrations varied substantially among manufacturers; however, all manufacturers were able to produce plain milk-based formulae containing less than 50 ng g(−1) Al, i.e. within the range of Al concentrations found in human milk. Next to soya-based and hypoallergenic formulae, premature formulae contained among the highest concentrations of Al, ranging 851–909 ng g(−1) from one manufacturer and 365–461 ng g(−1) from another.
format Online
Article
Text
id pubmed-3118527
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-31185272011-07-07 Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions Dabeka, Robert Fouquet, Andre Belisle, Stephane Turcotte, Stephane Food Addit Contam Part A Chem Anal Control Expo Risk Assess Research Article Lead (Pb), cadmium (Cd) and aluminum (Al) were determined in 437 individual samples of infant formulae, oral electrolytes and 5% glucose solutions available in Canada. In the electrolytes, Cd and Pb concentrations were all below 0.01 and 0.041 ng g(−1), respectively. In the 5% glucose solutions, Pb and Cd levels averaged 0.01 and 0.09 ng g(−1), respectively. Reported on an as-consumed basis, Pb levels in milk- and soya-based formulae averaged 0.90 and 1.45 ng g(−1), respectively, while Cd levels averaged 0.23 and 1.18 ng g(−1), respectively Average Al levels on an as-consumed basis were 440 ng g(−1) (range 10–3400 ng g(−1)) in milk-based formulae and 730 ng g(−1) (range 230–1100 ng g(−1)) in soy-based formulae. Al concentrations increased in the following order: plain formula < low-iron formula < iron-supplemented formula < casein hydrolysate formula ≈ premature formula ≤ soy formula. For example, in the powdered formulae, average Al concentrations were 18 ng g(−1) for plain milk-based, 37 ng g(−1) for low-iron, 128 ng g(−1) for iron supplemented, 462 ng g(−1) for lactose-free, 518 ng g(−1) for hypoallergenic and 619 ng g(−1) for soy-based formula. Al concentrations, as-consumed, increased with decreasing levels of concentration: powder < concentrated liquid < ready-to-use. Formulae stored in glass bottles contained between 100 and 300 ng g(−1) more Al than the same formulae stored in cans. The source of the increased Al did not appear to be the glass itself, because most electrolytes and glucose solutions, also stored in glass, contained less than 8 ng g(−1) Al. Corresponding differences in Pb and Cd levels were not observed. Al concentrations varied substantially among manufacturers; however, all manufacturers were able to produce plain milk-based formulae containing less than 50 ng g(−1) Al, i.e. within the range of Al concentrations found in human milk. Next to soya-based and hypoallergenic formulae, premature formulae contained among the highest concentrations of Al, ranging 851–909 ng g(−1) from one manufacturer and 365–461 ng g(−1) from another. Taylor & Francis 2011-05-31 2011-06 /pmc/articles/PMC3118527/ /pubmed/21623498 http://dx.doi.org/10.1080/19393210.2011.571795 Text en © 2011 Her Majesty the Queen in right of Canada http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf This is an open access article distributed under the Supplemental Terms and Conditions for iOpenAccess articles published in Taylor & Francis journals (http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dabeka, Robert
Fouquet, Andre
Belisle, Stephane
Turcotte, Stephane
Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions
title Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions
title_full Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions
title_fullStr Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions
title_full_unstemmed Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions
title_short Lead, cadmium and aluminum in Canadian infant formulae, oral electrolytes and glucose solutions
title_sort lead, cadmium and aluminum in canadian infant formulae, oral electrolytes and glucose solutions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118527/
https://www.ncbi.nlm.nih.gov/pubmed/21623498
http://dx.doi.org/10.1080/19393210.2011.571795
work_keys_str_mv AT dabekarobert leadcadmiumandaluminumincanadianinfantformulaeoralelectrolytesandglucosesolutions
AT fouquetandre leadcadmiumandaluminumincanadianinfantformulaeoralelectrolytesandglucosesolutions
AT belislestephane leadcadmiumandaluminumincanadianinfantformulaeoralelectrolytesandglucosesolutions
AT turcottestephane leadcadmiumandaluminumincanadianinfantformulaeoralelectrolytesandglucosesolutions